Checkmate Pharmaceuticals
is an innate immune receptor target with clinical proof of concept sting rig i | Checkmate Pharmaceuticals
Company
Deck Type
IPO
Deck date
August 2020
Slide
12 of 34
Related slides by other companies
Compass Therapeutics
IPO
November 2020
in innate and adaptive immune targets | Compass Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights